Please use this identifier to cite or link to this item:
|Title:||Clinical pharmacology and pharmacogenetics of gemcitabine||Authors:||Wong, A.
|Issue Date:||May-2009||Citation:||Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F. (2009-05). Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metabolism Reviews 41 (2) : 77-88. ScholarBank@NUS Repository. https://doi.org/10.1080/03602530902741828||Abstract:||Gemcitabine is a cytotoxic nucleoside analog, which is widely used in the treatment of malignancies. Interindividual differences in gemcitabine pharmacokinetics and pharmacodynamics have been demonstrated. Pharmacogenetic factors may account for a significant proportion of these differences. This review provides an update on the pharmacogenetics of gemcitabine and its influence on gemcitabine efficacy and toxicity. © 2009 Informa UK Ltd.||Source Title:||Drug Metabolism Reviews||URI:||http://scholarbank.nus.edu.sg/handle/10635/115536||ISSN:||03602532||DOI:||10.1080/03602530902741828|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.